Issues in the psychiatric screening of cancer patients

Current Psychiatry Reviews

Volumn 2, Issue 1, 2006, Pages 3-10

  Martin, Colin R ^a   Cheng, Karis K F ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Chemotherapy; DSM IV; Hospital Anxiety and Depression Scale (HADS); Major Depression Inventory (MDI); Mood disorder; Persistent reactive distress; Psychological crisis

Indexed keywords

ANTINEOPLASTIC AGENT;

ANXIETY DISORDER; BECK DEPRESSION INVENTORY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CLINICAL PATHWAY; CLINICAL PRACTICE; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DISTRESS SYNDROME; EDINBURGH POSTNATAL DEPRESSION SCALE; GENERAL HEALTH QUESTIONNAIRE; HEAD AND NECK CANCER; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; KIDNEY CARCINOMA; LIAISON PSYCHIATRY; LYMPHOMA; MASTECTOMY; MELANOMA; MENTAL DISEASE; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PATIENT REFERRAL; PLASMA CELL DYSCRASIA; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; UNSPECIFIED SIDE EFFECT;

EID: 33745819239     PISSN: 15734005     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340006775101472     Document Type: Review

References (99)

1. Spiegel D. Psychological distress and disease course for women with breast cancer: one answer, many questions. J Natl Cancer Inst 1996; 88: 629-631.
2. Breitbart W. Psychiatric management of cancer pain. Cancer 1989; 63 (Suppl 11): 2336-42.
3. Breitbart W. Psycho-oncology: depression, anxiety, delirium. Semin Oncol 1994; 21: 754-69.
4. Berard RM, Boermeester F, Viljoen G. Depressive disorders in an out-patient oncology setting: prevalence, assessment, and management. Psychooncology 1998; 7: 112-20.
5. Palapattu GS, Bastian PJ, Slavney PR, et al. Preoperative somatic symptoms are associated with disease progression in patients with bladder carcinoma after cystectomy. Cancer 2004; 101: 2209-13.
6. Buccheri G, Ferrigno D. Prognostic factors. Hematol Oncol Clin North Am 2004; 18: 187-201.
7. Bergenmar M, Nilsson B, Hansson J, Brandberg Y. Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma. Acta Oncol 2004; 43: 161-8.
8. Fritzsche K, Struss Y, Stein B, Spahn C. Psychosomatic liaison service in hematological oncology: need for psychotherapeutic interventions and their realization. Hematol Oncol 2003; 21: 83-9.
9. Carney CP, Yates WR, Goerdt CJ, Doebbeling BN. Psychiatrists' and internists' knowledge and attitudes about delivery of clinical preventive medical services. Psychiatr Serv 1998; 49: 1594-600.
10. Brown JH, Varsamis J, Toews J, Shane M. Psychiatry and oncology: a review. Can Psychiatr Assoc J 1974; 19: 219-22.
11. Berard RM. Depression and anxiety in oncology: the psychiatrist's perspective. J Clin Psychiatry 2001; 62 Suppl 8: 58-61.
12. Canning EH, Canning RD, Boyce WT. Depressive symptoms and adaptive style in children with cancer. J Am Acad Child Adolesc Psychiatry 1992; 31: 1120-24.
13. Borysenko JZ. Behavioral - physiological factors in the development and management of cancer. Gen Hosp Psychiatry 1982; 4: 69-74.
14. Glanz K, Rimer BK, Lerman C, McGovern GP. Factors influencing acceptance of mammography: implications for enhancing worksite cancer control. Am J Health Promot 1992; 7: 28-36.
15. Grassi L, Indelli M, Marzola M, et al. Depressive symptoms and quality of life in home-care-assisted cancer patients. J Pain Symptom Manage 1996; 12: 300-7.
16. McDaniel JS, Musselman DL, Porter MR, Reed DA, Nemeroff CB. Depression in patients with cancer. Diagnosis, biology, and treatment. Arch Gen Psychiatry 1995; 52: 89-99.
17. Minagawa H, Uchitomi Y, Yamawaki S, Ishitani K. Psychiatric morbidity in terminally ill cancer patients. A prospective study. Cancer 1996; 78: 1131-7.
18. Sharpe M, Strong V, Allen K, et al. Management of major depression in outpatients attending a cancer centre: a preliminary evaluation of a multicomponent cancer nurse-delivered intervention. Br J Cancer 2004; 90: 310-13.
19. Walker LG, Heys SD, Walker MB, et al. Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer. Eur J Cancer 1999; 35: 1783-8.
20. Hopwood P, Howell A, Maguire P. Psychiatric morbidity in patients with advanced cancer of the breast: prevalence measured by two self-rating questionnaires. Br J Cancer 1991; 64: 349-52.
21. Faller H, Bulzebruck H, Drings P, Lang H. Coping, distress, and survival among patients with lung cancer. Arch Gen Psychiatry 1999; 56: 756-62.
22. Ryan H, Schofield P, Cockburn J, et al. How to recognize and manage psychological distress in cancer patients. Eur J Cancer Care 2005; 14: 7-15.
23. Spiegel D. Cancer and depression. Br J Psychiatry Suppl 1996; 30: 109-16.
24. Spiegel D. Psychosocial aspects of breast cancer treatment. Semin Oncol 1997; 24 (Suppl 1): SI.
25. Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 1990; 156: 79-83.
26. Dugan W, McDonald MV, Passik SD, Rosenfeld BD, Theobald D, Edgerton S. Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool. Psychooncology 1998; 7: 483-93.
27. Newport DJ, Nemeroff CB. Assessment and treatment of depression in the cancer patient. J Psychosom Res 1998; 45: 215-37.
28. Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002; 20: 3137-48.
29. Stommel M, Given BA, Given CW. Depression and functional status as predictors of death among cancer patients. Cancer 2003; 94: 2719-27.
30. Brown KW, Levy AR, Rosberger Z, Edgar L. Psychological distress and cancer survival: a follow-up 10 years after diagnosis. Psychosom Med 2003; 65: 636-43.
31. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology 2001; 10: 19-28.
32. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-7.
33. Payne DK, Massie MJ. Depression and anxiety. In: Berger AM, Portenoy RK, Weissman DE, editors. Principles and Practice of Palliative Care and Supportive Oncology. Philadelphia: J.B. Lippincott, 2002: 577-592.
34. Massie MJ, Popkin MK. Depressive disorder. In: Holland L, editor. Psycho-Oncology. New York: Oxford University Press, 1998: 518-540.
35. DeFlorio M, Massie MJ. Review of depression in cancer: gender differences. Depression 1995; 3: 66-80.
36. Derogatis LR, Morrow GR, Fetting J, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249: 751-757.
37. Akechi T, Okuyama T, Sugawara Y, Nakano T, Shima Y, Uchitomi Y. Major depression, adjustment disorders, and posttraumatic stress disorder in terminally ill cancer patients: associated and predictive factors. J Clin Oncol 2004; 22: 1957-65.
38. Massie MJ, Holland JC. The cancer patient with pain: psychiatric complications and their management. Med Clin North Am 1987; 71: 243-58.
39. Portenoy RK, Payne D, Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 1999; 81: 129-34.
40. Harcourt DM, Rumsey NJ, Ambler NR, et al. The psychological effect of mastectomy with or without breast reconstruction: a prospective, multicenter study. Plast Reconstr Surg 2003; 111: 1060-8.
41. Brandberg Y, Bolund C, Sigurdardottir V. Anxiety and depressive symptoms at different stages of malignant melanoma. Psychooncology 1992; 1: 71-6.
42. Gotay CC, Isaacs P, Pagano I. Quality of life in patients who survive a dire prognosis compared to control cancer survivors. Psychooncology 2004; 13: 882-92.
43. Rabin C, Ward S, Leventhal H, Schmitz M. Explaining retrospective reports of symptoms in patients undergoing chemotherapy: anxiety, initial symptom experience, and posttreatment symptoms. Health Psychol 2001; 20: 91-8.
44. Cheng JYY. The illness experience of patients with nasopharyngeal carcinoma (NPC): psychosocial support services. In: Fielding R, Chan CLW, editors. Psychosocial Oncology and Palliative Care in Hong Kong: The First Decade. Hong Kong: Hong Kong University Press, 2000: 125-142.
45. Glajchen M. Psychosocial issues in cancer care. In: Miaskowski C, Buchsel P, editors. Oncology Nursing: Assessment and Clinical Care. St Louis: Mosby, 1999: 305-318.
46. Kvale G, Glimelius B, Hoffman K, Sjoden PO. Pre-chemotherapy nervousness as a marker of anticipatory nausea: a case of a noncausal predictor. Eur J Cancer 1993; 29: S210.
47. Holland JC. Anxiety and cancer: the patient and the family. J Clin Psychiatry 1989; 50 Suppl: 20-25.
48. Fritzsche K, Liptai C, Henke M. Psychosocial distress and need for psychotherapeutic treatment in cancer patients undergoing radiotherapy. Radiother Oncol 2004; 72: 183-9.
49. Munro AJ, Biruls R, Griffin AV, Thomas H, Vallis KA. Distress associated with radiotherapy for malignant disease: a quantitative analysis based on patients perceptions. Br J Cancer 1989; 60: 370-4.
50. Katz MR, Irish JC, Devins GM, Rodin GM, Gullane PJ. Psychosocial adjustment in head and neck cancer: the impact of disfigurement, gender and social support. Head Neck 2003; 25: 103-12.
51. David JD, Barritt JA. Psychosocial implications of surgery for head and neck cancer. Clin Plastic Sur 1982; 9: 327-36.
52. Maguire P, Hopwood P, Tarrier N, Howell T. Treatment of depression in cancer patients. Acta Psychiatr Scand Suppl 1985; 320: 81-4.
53. Martin CR. What does the Hospital Anxiety and Depression Scale (HADS) Really Measure in Liaison Psychiatry Settings? Current Psychiatry Reviews 2005; 1: 69-73.
54. Osborne RH, Elsworth GR, Sprangers MA, Oort FJ, Hopper JL. The value of the Hospital Anxiety and Depression Scale (HADS) for comparing women with early onset breast cancer with population-based reference women. Qual Life Res 2004; 13: 191-206.
55. Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L. Screening for anxiety and depression in cancer patients: the effects of disease and treatment. Eur J Cancer 1994; 30: 37-40.
56. Anderson J, Walker MB, Walker LG. The Mood Rating Scale: a brief, acceptable, reliable and valid state measure of normal mood. Psychooncology 2000; 9: 359.
57. Nordin K, Berglund G, Terje I, Glimelius B. The Mental Adjustment to Cancer Scale-a psychometric analysis and the concept of coping. Psychooncology 1999; 8: 250-9.
58. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-70.
59. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
60. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale - a review of validation data and clinical results. J Psychosom Res 1997; 42: 17-41.
61. Lloyd-Williams M, Friedman T, Rudd N. An analysis of the validity of the Hospital Anxiety and Depression scale as a screening tool in patients with advanced metastatic cancer. J Pain Symptom Manage 2001; 22: 990-6.
62. Cliff AM, MacDonagh RP. Psychosocial morbidity in prostate cancer: II. A comparison of patients and partners. BJU Int 2000; 86: 834-9.
63. Bang SM, Park SH, Kang HG, et al. Changes in quality of life during palliative chemotherapy for solid cancer. Support Care Cancer 2005 (epub ahead of print).
64. Chen ML, Chang HK, Yeh CH. Anxiety and depression in Taiwanese cancer patients with and without pain. J Adv Nurs 2000; 32: 944-51.
65. Ballenger JC, Davidson JR, Lecrubier Y, Nutt DJ, Jones RD, Berard RM. Consensus statement on depression, anxiety, and oncology. J Clin Psychiatry 2001; 62 Suppl 8: 64-7.
66. Carroll BT, Kathol RG, Noyes R Jr, Wald TG, Clamon GH. Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale. Gen Hosp Psychiatry 1993; 15: 69-74.
67. Ekeberg O, Skjauff H, Karesen R. Screening for breast cancer is associated with a low degree of psychological distress. Breast 2001; 10: 20-24.
68. Smith AB, Selby PJ, Velikova G, et al. Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population. Psychol Psychother 2002; 75: 165-76.
69. Fossa SD, Dahl AA. Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer. J Psychosom Res 2002; 52: 79-87.
70. Johnston M, Pollard B, Hennessey P. Construct validation of the hospital anxiety and depression scale with clinical populations. J Psychosom Res 2000; 48: 579-84.
71. Hall A, A'Hern R, Fallowfield L. Are we using appropriate self-report questionnaires for detecting anxiety and depression in women with early breast cancer? Eur J Cancer 1999; 35: 79-85.
72. Love AW, Kissane DW, Bloch S, Clarke D. Diagnostic efficiency of the Hospital Anxiety and Depression Scale in women with early stage breast cancer. Aust N Z J Psychiatry 2002; 36: 246-50.
73. Chaturvedi SK, Maguire GP. Persistent somatization in cancer: a controlled follow-up study. J Psychosom Res 1998; 45: 249-56.
74. Lewis G, Wessely S. Comparison of the General Health Questionnaire and the Hospital Anxiety and Depression Scale. Br J Psychiatry 1990; 157: 860-4.
75. Ramirez AJ, Richards MA, Jarrett SR, Fentiman IS. Can mood disorder in women with breast cancer be identified preoperatively? Br J Cancer 1995; 72: 1509-12.
76. Snaith RP, Zigmond AS. The Hospital Anxiety and Depression Scale Manual. Windsor: NFER-Nelson, 1994.
77. Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 1987; 150: 782-6.
78. Ross LE, Gilbert Evans SE, Sellers EM, Romach MK. Measurement issues in postpartum depression part 1: anxiety as a feature of postpartum depression. Arch Women Ment Health 2003; 6: 51-7.
79. Brouwers EP, van Baar AL, Pop VJ. Does the Edinburgh Postnatal Depression Scale measure anxiety? J Psychosom Res 2001; 51: 659-63.
80. Jomeen J, Martin CR. Is the Hospital Anxiety and Depression Scale (HADS) a reliable screening tool in early pregnancy? Psychol Health 2004; 19: 787-800.
81. Lloyd-Williams M, Friedman T, Rudd N. Criterion validation of the Edinburgh postnatal depression scale as a screening tool for depression in patients with advanced metastatic cancer. J Pain Symptom Manage 2000; 20: 259-65.
82. Goldberg D, Williams PA. Users Guide to General Health Questionnaire, Windsor: NFER-Nelson, 1988.
83. Beck AT , Ward CH , Mendelson M , Mock J , Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
84. Storch EA, Roberti JW, Roth DA. Factor structure, concurrent validity, and internal consistency of the Beck Depression Inventory-Second Edition in a sample of college students. Depress Anxiety 2004; 19: 187-9.
85. Radloff LF. The CES-D: a self-report depression scale for use in the general population. App Psychol Measure 1977; 3: 385-401.
86. Bottomley A. Depression in cancer patients: a literature review. Eur J Cancer Care 1998; 7: 181-91.
87. Pirraglia PA, Sanyal P, Singer DE, Ferris TG. Depressive symptom burden as a barrier to screening for breast and cervical cancers. J Womens Health (Larchmt) 2004; 13: 731-8.
88. Day R, Ganz PA, Costantino JP. Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study. J Natl Cancer Inst 2001; 93: 1615-23.
89. Vernon SW, Gritz ER, Peterson SK, et al. Correlates of psychologic distress in colorectal cancer patients undergoing genetic testing for hereditary colon cancer. Health Psychol 1997; 16: 73-86.
90. Hann D, Winter K, Jacobsen P. Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D). J Psychosom Res 1999; 46: 437-43.
91. Carpenter JS, Andrykowski MA, Wilson J, et al. Psychometrics for two short forms of the Center for Epidemiologic Studies-Depression Scale. Issues Ment Health Nurs 1998; 19: 481-94.
92. Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W. The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. J Affect Disord 2001; 66: 159-64.
93. McHorney CA, Monahan PO. Postscript: Applications of Rasch analysis in health care. Med Care 2004; 42 (1 Suppl): 173-8.
94. Sorensen C, Brandes A, Hendricks O, et al. Psychosocial predictors of depression in patients with acute coronary syndrome. Acta Psychiatr Scand 2005; 111: 116-24.
95. Katz MR, Kopek N, Waldron J, Devins GM, Tomlinson G. Screening for depression in head and neck cancer. Psychooncology 2004; 13: 269-80.
96. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 1998; 82: 1904-8.
97. Jacobsen PB, Donovan KA, Trask PC, et al. Screening for psychologic distress in ambulatory cancer patients. Cancer 2005; 103: 1494-502.
98. Allgar VL, Neal RD, Pascoe SW. Cancer patients consultation patterns in primary care and levels of psychological morbidity: findings from the Health Survey for England. Psychooncology 2003; 12: 736-40.
99. Goldberg D. The management of anxious depression in primary care. J Clin Psychiatry 1999; 60: 39-42.